BlackRock Institutional Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $481M | Buy |
6,532,503
+40,282
| +0.6% | +$2.97M | 0.07% | 275 |
|
|
2016
Q3 | $566M | Buy |
6,492,221
+144,397
| +2% | +$12.6M | 0.09% | 237 |
|
|
2016
Q2 | $546M | Buy |
6,347,824
+9,670
| +0.2% | +$832K | 0.09% | 237 |
|
|
2016
Q1 | $504M | Buy |
6,338,154
+86,478
| +1% | +$6.87M | 0.08% | 242 |
|
|
2015
Q4 | $787M | Buy |
6,251,676
+81,517
| +1% | +$10.3M | 0.13% | 153 |
|
|
2015
Q3 | $643M | Sell |
6,170,159
-214,196
| -3% | -$22.3M | 0.11% | 186 |
|
|
2015
Q2 | $788M | Sell |
6,384,355
-76,522
| -1% | -$9.45M | 0.13% | 160 |
|
|
2015
Q1 | $762M | Buy |
6,460,877
+144,910
| +2% | +$17.1M | 0.12% | 178 |
|
|
2014
Q4 | $750M | Buy |
6,315,967
+124,032
| +2% | +$14.7M | 0.12% | 177 |
|
|
2014
Q3 | $695M | Buy |
6,191,935
+129,338
| +2% | +$14.5M | 0.12% | 177 |
|
|
2014
Q2 | $574M | Buy |
6,062,597
+28,401
| +0.5% | +$2.69M | 0.1% | 217 |
|
|
2014
Q1 | $427M | Buy |
6,034,196
+46,187
| +0.8% | +$3.27M | 0.07% | 257 |
|
|
2013
Q4 | $445M | Sell |
5,988,009
-97,492
| -2% | -$7.24M | 0.08% | 241 |
|
|
2013
Q3 | $461M | Buy |
6,085,501
+249,358
| +4% | +$18.9M | 0.09% | 224 |
|
|
2013
Q2 | $467M | Buy |
+5,836,143
| New | +$467M | 0.09% | 214 |
|